Related Experiment Videos
Appendicular fractures: a significant problem among institutionalized adults with developmental disabilities.
K M Ryder1, J Williams, C Womack
1Memphis Metabolic Bone Center, University of Tennessee, Memphis, TN 38163, USA. kryder@utmem.edu
American Journal of Mental Retardation : AJMR
|August 7, 2003
Summary
Fractures are common in adults with developmental disabilities. Low bone mineral density (BMD) and antiepileptic drugs may increase fracture risk in this population.
Area of Science:
- Gerontology
- Public Health
- Neurology
Background:
- Nontraumatic fractures represent a significant health concern in adults with developmental disabilities.
- Institutionalized individuals with severe developmental disabilities exhibit a high incidence of fractures.
- Identifying risk factors is crucial for proactive fracture prevention strategies.
Purpose of the Study:
- To investigate the incidence of nontraumatic fractures in adults with developmental disabilities residing in a state-run facility.
- To identify potential risk factors, including bone mineral density (BMD), associated with fractures in this population.
- To determine if individuals at highest risk for fracture can be prospectively identified.
Main Methods:
- A retrospective review of 391 adults with developmental disabilities was conducted.
- Fracture risk factors were examined in 23 residents with fractures and 23 matched controls.
- Bone mineral density (BMD) was estimated using heel ultrasound.
Main Results:
- The incidence of fracture was 7.3% among the 391 adults studied.
- A trend suggested an association between antiepileptic medication usage and fractures.
- Heel ultrasound-derived BMD did not predict fractures but revealed significantly lower values compared to the general population.
Conclusions:
- Fractures and low bone mineral density (BMD) are prevalent issues in institutionalized adults with severe developmental disabilities.
- Antiepileptic medication use may be a contributing factor to fracture risk.
- Further research is needed to develop effective therapies for fracture prevention in this vulnerable group.